Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Report 2017

Name: Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Report 2017
Brand: QYResearch
SKU: G455660255BPEN
Price: 4000 USD
Availability: InStock

October 2017 | 119 pages | ID: G455660255BPEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer

Checkout Later

Need Help? Ask a Question

In this report, the global Benign Prostatic Hyperplasia (BPH) Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (MT), revenue (Million USD), market share and growth rate of Benign Prostatic Hyperplasia (BPH) Drugs for these regions, from 2012 to 2022 (forecast), covering

United States
China
Europe
Japan
Southeast Asia
India

Global Benign Prostatic Hyperplasia (BPH) Drugs market competition by top manufacturers/players, with Benign Prostatic Hyperplasia (BPH) Drugs sales volume, Price (USD/Kg), revenue (Million USD) and market share for each manufacturer/player; the top players including

Astellas Pharma
Eli Lilly
GlaxoSmithKline
Sanofi
ADC Therapeutics
Advaxis
Agennix
ANI Pharmaceuticals
BHR Pharma
Bristol-Myers Squibb
Boehringer Ingelheim
Dendreo
Endo Pharmaceuticals

On the basis of product, this report displays the sales volume (MT), revenue (Million USD), product price (USD/Kg), market share and growth rate of each type, primarily split into

Alpha-blocker
Phosphodiesterase type-5 inhibitors
5-alpha-Reductase inhibitors

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Benign Prostatic Hyperplasia (BPH) Drugs for each application, including

Clinical medicine
Scientific research
Others

Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Report 2017

1 BENIGN PROSTATIC HYPERPLASIA (BPH) DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Benign Prostatic Hyperplasia (BPH) Drugs
1.2 Classification of Benign Prostatic Hyperplasia (BPH) Drugs by Product Category
  1.2.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Alpha-blocker
  1.2.4 Phosphodiesterase type-5 inhibitors
  1.2.5 5-alpha-Reductase inhibitors
1.3 Global Benign Prostatic Hyperplasia (BPH) Drugs Market by Application/End Users
  1.3.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022)
  1.3.2 Clinical medicine
  1.3.3 Scientific research
  1.3.4 Others
1.4 Global Benign Prostatic Hyperplasia (BPH) Drugs Market by Region
  1.4.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 United States Benign Prostatic Hyperplasia (BPH) Drugs Status and Prospect (2012-2022)
  1.4.3 China Benign Prostatic Hyperplasia (BPH) Drugs Status and Prospect (2012-2022)
  1.4.4 Europe Benign Prostatic Hyperplasia (BPH) Drugs Status and Prospect (2012-2022)
  1.4.5 Japan Benign Prostatic Hyperplasia (BPH) Drugs Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Status and Prospect (2012-2022)
  1.4.7 India Benign Prostatic Hyperplasia (BPH) Drugs Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Benign Prostatic Hyperplasia (BPH) Drugs (2012-2022)
  1.5.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate (2012-2022)
  1.5.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Growth Rate (2012-2022)

2 GLOBAL BENIGN PROSTATIC HYPERPLASIA (BPH) DRUGS COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Market Competition by Players/Suppliers
  2.1.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Benign Prostatic Hyperplasia (BPH) Drugs (Volume and Value) by Type
  2.2.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Market Share by Type (2012-2017)
2.3 Global Benign Prostatic Hyperplasia (BPH) Drugs (Volume and Value) by Region
  2.3.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales and Market Share by Region (2012-2017)
  2.3.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Market Share by Region (2012-2017)
2.4 Global Benign Prostatic Hyperplasia (BPH) Drugs (Volume) by Application

3 UNITED STATES BENIGN PROSTATIC HYPERPLASIA (BPH) DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 United States Benign Prostatic Hyperplasia (BPH) Drugs Sales and Value (2012-2017)
  3.1.1 United States Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate (2012-2017)
  3.1.2 United States Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Growth Rate (2012-2017)
  3.1.3 United States Benign Prostatic Hyperplasia (BPH) Drugs Sales Price Trend (2012-2017)
3.2 United States Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume and Market Share by Players
3.3 United States Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume and Market Share by Type
3.4 United States Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume and Market Share by Application

4 CHINA BENIGN PROSTATIC HYPERPLASIA (BPH) DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 China Benign Prostatic Hyperplasia (BPH) Drugs Sales and Value (2012-2017)
  4.1.1 China Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate (2012-2017)
  4.1.2 China Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Growth Rate (2012-2017)
  4.1.3 China Benign Prostatic Hyperplasia (BPH) Drugs Sales Price Trend (2012-2017)
4.2 China Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume and Market Share by Players
4.3 China Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume and Market Share by Type
4.4 China Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume and Market Share by Application

5 EUROPE BENIGN PROSTATIC HYPERPLASIA (BPH) DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales and Value (2012-2017)
  5.1.1 Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate (2012-2017)
  5.1.2 Europe Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Growth Rate (2012-2017)
  5.1.3 Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales Price Trend (2012-2017)
5.2 Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume and Market Share by Players
5.3 Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume and Market Share by Type
5.4 Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume and Market Share by Application

6 JAPAN BENIGN PROSTATIC HYPERPLASIA (BPH) DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Benign Prostatic Hyperplasia (BPH) Drugs Sales and Value (2012-2017)
  6.1.1 Japan Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate (2012-2017)
  6.1.2 Japan Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Growth Rate (2012-2017)
  6.1.3 Japan Benign Prostatic Hyperplasia (BPH) Drugs Sales Price Trend (2012-2017)
6.2 Japan Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume and Market Share by Players
6.3 Japan Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume and Market Share by Type
6.4 Japan Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume and Market Share by Application

7 SOUTHEAST ASIA BENIGN PROSTATIC HYPERPLASIA (BPH) DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales and Value (2012-2017)
  7.1.1 Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales Price Trend (2012-2017)
7.2 Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume and Market Share by Players
7.3 Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume and Market Share by Type
7.4 Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume and Market Share by Application

8 INDIA BENIGN PROSTATIC HYPERPLASIA (BPH) DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 India Benign Prostatic Hyperplasia (BPH) Drugs Sales and Value (2012-2017)
  8.1.1 India Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate (2012-2017)
  8.1.2 India Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Growth Rate (2012-2017)
  8.1.3 India Benign Prostatic Hyperplasia (BPH) Drugs Sales Price Trend (2012-2017)
8.2 India Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume and Market Share by Players
8.3 India Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume and Market Share by Type
8.4 India Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume and Market Share by Application

9 GLOBAL BENIGN PROSTATIC HYPERPLASIA (BPH) DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 Astellas Pharma
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Benign Prostatic Hyperplasia (BPH) Drugs Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Astellas Pharma Benign Prostatic Hyperplasia (BPH) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 Eli Lilly
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Benign Prostatic Hyperplasia (BPH) Drugs Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Eli Lilly Benign Prostatic Hyperplasia (BPH) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 GlaxoSmithKline
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Benign Prostatic Hyperplasia (BPH) Drugs Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 GlaxoSmithKline Benign Prostatic Hyperplasia (BPH) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 Sanofi
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Benign Prostatic Hyperplasia (BPH) Drugs Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 Sanofi Benign Prostatic Hyperplasia (BPH) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 ADC Therapeutics
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Benign Prostatic Hyperplasia (BPH) Drugs Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 ADC Therapeutics Benign Prostatic Hyperplasia (BPH) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview
9.6 Advaxis
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Benign Prostatic Hyperplasia (BPH) Drugs Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 Advaxis Benign Prostatic Hyperplasia (BPH) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.6.4 Main Business/Business Overview
9.7 Agennix
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Benign Prostatic Hyperplasia (BPH) Drugs Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 Agennix Benign Prostatic Hyperplasia (BPH) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.7.4 Main Business/Business Overview
9.8 ANI Pharmaceuticals
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Benign Prostatic Hyperplasia (BPH) Drugs Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 ANI Pharmaceuticals Benign Prostatic Hyperplasia (BPH) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.8.4 Main Business/Business Overview
9.9 BHR Pharma
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Benign Prostatic Hyperplasia (BPH) Drugs Product Category, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 BHR Pharma Benign Prostatic Hyperplasia (BPH) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.9.4 Main Business/Business Overview
9.10 Bristol-Myers Squibb
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Benign Prostatic Hyperplasia (BPH) Drugs Product Category, Application and Specification
    9.10.2.1 Product A
    9.10.2.2 Product B
  9.10.3 Bristol-Myers Squibb Benign Prostatic Hyperplasia (BPH) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.10.4 Main Business/Business Overview
9.11 Boehringer Ingelheim
9.12 Dendreo
9.13 Endo Pharmaceuticals

10 BENIGN PROSTATIC HYPERPLASIA (BPH) DRUGS MAUFACTURING COST ANALYSIS

10.1 Benign Prostatic Hyperplasia (BPH) Drugs Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Benign Prostatic Hyperplasia (BPH) Drugs
10.3 Manufacturing Process Analysis of Benign Prostatic Hyperplasia (BPH) Drugs

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Benign Prostatic Hyperplasia (BPH) Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Benign Prostatic Hyperplasia (BPH) Drugs Major Manufacturers in 2016
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL BENIGN PROSTATIC HYPERPLASIA (BPH) DRUGS MARKET FORECAST (2017-2022)

14.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
  14.1.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume and Growth Rate Forecast (2017-2022)
  14.1.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global Benign Prostatic Hyperplasia (BPH) Drugs Price and Trend Forecast (2017-2022)
14.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  14.2.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume and Growth Rate Forecast by Regions (2017-2022)
  14.2.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.3 United States Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 China Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 Japan Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.7 Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.8 India Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume, Revenue and Price Forecast by Type (2017-2022)
  14.3.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Forecast by Type (2017-2022)
  14.3.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Forecast by Type (2017-2022)
  14.3.3 Global Benign Prostatic Hyperplasia (BPH) Drugs Price Forecast by Type (2017-2022)
14.4 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

LIST OF TABLES AND FIGURES

Figure Product Picture of Benign Prostatic Hyperplasia (BPH) Drugs
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Comparison (MT) by Type (2012-2022)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Alpha-blocker Product Picture
Figure Phosphodiesterase type-5 inhibitors Product Picture
Figure 5-alpha-Reductase inhibitors Product Picture
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Comparison (MT) by Application (2012-2022)
Figure Global Sales Market Share of Benign Prostatic Hyperplasia (BPH) Drugs by Application in 2016
Figure Clinical medicine Examples
Figure Scientific research Examples
Figure Others Examples
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Market Size (Million USD) by Regions (2012-2022)
Figure United States Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (MT) and Growth Rate (2012-2022)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (MT) (2012-2017)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales (MT) of Key Players/Suppliers (2012-2017)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Benign Prostatic Hyperplasia (BPH) Drugs Sales Share by Players/Suppliers
Figure 2017 Benign Prostatic Hyperplasia (BPH) Drugs Sales Share by Players/Suppliers
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Share by Players
Table 2017 Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Share by Players
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales (MT) and Market Share by Type (2012-2017)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Share (MT) by Type (2012-2017)
Figure Sales Market Share of Benign Prostatic Hyperplasia (BPH) Drugs by Type (2012-2017)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Growth Rate by Type (2012-2017)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Benign Prostatic Hyperplasia (BPH) Drugs by Type (2012-2017)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Growth Rate by Type (2012-2017)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (MT) and Market Share by Region (2012-2017)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Benign Prostatic Hyperplasia (BPH) Drugs by Region (2012-2017)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Growth Rate by Region in 2016
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Benign Prostatic Hyperplasia (BPH) Drugs by Region (2012-2017)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Growth Rate by Region in 2016
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Benign Prostatic Hyperplasia (BPH) Drugs by Region (2012-2017)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share by Region in 2016
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (MT) and Market Share by Application (2012-2017)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Benign Prostatic Hyperplasia (BPH) Drugs by Application (2012-2017)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Share by Application (2012-2017)
Figure United States Benign Prostatic Hyperplasia (BPH) Drugs Sales (MT) and Growth Rate (2012-2017)
Figure United States Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Benign Prostatic Hyperplasia (BPH) Drugs Sales Price (USD/Kg) Trend (2012-2017)
Table United States Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (MT) by Players (2012-2017)
Table United States Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Players (2012-2017)
Figure United States Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Players in 2016
Table United States Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (MT) by Type (2012-2017)
Table United States Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Type (2012-2017)
Figure United States Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Type in 2016
Table United States Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (MT) by Application (2012-2017)
Table United States Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Application (2012-2017)
Figure United States Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Application in 2016
Figure China Benign Prostatic Hyperplasia (BPH) Drugs Sales (MT) and Growth Rate (2012-2017)
Figure China Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Benign Prostatic Hyperplasia (BPH) Drugs Sales Price (USD/Kg) Trend (2012-2017)
Table China Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (MT) by Players (2012-2017)
Table China Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Players (2012-2017)
Figure China Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Players in 2016
Table China Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (MT) by Type (2012-2017)
Table China Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Type (2012-2017)
Figure China Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Type in 2016
Table China Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (MT) by Application (2012-2017)
Table China Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Application (2012-2017)
Figure China Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Application in 2016
Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales Price (USD/Kg) Trend (2012-2017)
Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (MT) by Players (2012-2017)
Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Players (2012-2017)
Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Players in 2016
Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (MT) by Type (2012-2017)
Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Type (2012-2017)
Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Type in 2016
Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (MT) by Application (2012-2017)
Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Application (2012-2017)
Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Application in 2016
Figure Japan Benign Prostatic Hyperplasia (BPH) Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Japan Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Benign Prostatic Hyperplasia (BPH) Drugs Sales Price (USD/Kg) Trend (2012-2017)
Table Japan Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (MT) by Players (2012-2017)
Table Japan Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Players (2012-2017)
Figure Japan Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Players in 2016
Table Japan Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (MT) by Type (2012-2017)
Table Japan Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Type (2012-2017)
Figure Japan Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Type in 2016
Table Japan Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (MT) by Application (2012-2017)
Table Japan Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Application (2012-2017)
Figure Japan Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Application in 2016
Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales Price (USD/Kg) Trend (2012-2017)
Table Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (MT) by Players (2012-2017)
Table Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Players in 2016
Table Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (MT) by Type (2012-2017)
Table Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Type in 2016
Table Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (MT) by Application (2012-2017)
Table Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Application in 2016
Figure India Benign Prostatic Hyperplasia (BPH) Drugs Sales (MT) and Growth Rate (2012-2017)
Figure India Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Benign Prostatic Hyperplasia (BPH) Drugs Sales Price (USD/Kg) Trend (2012-2017)
Table India Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (MT) by Players (2012-2017)
Table India Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Players (2012-2017)
Figure India Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Players in 2016
Table India Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (MT) by Type (2012-2017)
Table India Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Type (2012-2017)
Figure India Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Type in 2016
Table India Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (MT) by Application (2012-2017)
Table India Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Application (2012-2017)
Figure India Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share by Application in 2016
Table Astellas Pharma Basic Information List
Table Astellas Pharma Benign Prostatic Hyperplasia (BPH) Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Astellas Pharma Benign Prostatic Hyperplasia (BPH) Drugs Sales Growth Rate (2012-2017)
Figure Astellas Pharma Benign Prostatic Hyperplasia (BPH) Drugs Sales Global Market Share (2012-2017
Figure Astellas Pharma Benign Prostatic Hyperplasia (BPH) Drugs Revenue Global Market Share (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Benign Prostatic Hyperplasia (BPH) Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Eli Lilly Benign Prostatic Hyperplasia (BPH) Drugs Sales Growth Rate (2012-2017)
Figure Eli Lilly Benign Prostatic Hyperplasia (BPH) Drugs Sales Global Market Share (2012-2017
Figure Eli Lilly Benign Prostatic Hyperplasia (BPH) Drugs Revenue Global Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Benign Prostatic Hyperplasia (BPH) Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Benign Prostatic Hyperplasia (BPH) Drugs Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Benign Prostatic Hyperplasia (BPH) Drugs Sales Global Market Share (2012-2017
Figure GlaxoSmithKline Benign Prostatic Hyperplasia (BPH) Drugs Revenue Global Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Benign Prostatic Hyperplasia (BPH) Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Sanofi Benign Prostatic Hyperplasia (BPH) Drugs Sales Growth Rate (2012-2017)
Figure Sanofi Benign Prostatic Hyperplasia (BPH) Drugs Sales Global Market Share (2012-2017
Figure Sanofi Benign Prostatic Hyperplasia (BPH) Drugs Revenue Global Market Share (2012-2017)
Table ADC Therapeutics Basic Information List
Table ADC Therapeutics Benign Prostatic Hyperplasia (BPH) Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure ADC Therapeutics Benign Prostatic Hyperplasia (BPH) Drugs Sales Growth Rate (2012-2017)
Figure ADC Therapeutics Benign Prostatic Hyperplasia (BPH) Drugs Sales Global Market Share (2012-2017
Figure ADC Therapeutics Benign Prostatic Hyperplasia (BPH) Drugs Revenue Global Market Share (2012-2017)
Table Advaxis Basic Information List
Table Advaxis Benign Prostatic Hyperplasia (BPH) Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Advaxis Benign Prostatic Hyperplasia (BPH) Drugs Sales Growth Rate (2012-2017)
Figure Advaxis Benign Prostatic Hyperplasia (BPH) Drugs Sales Global Market Share (2012-2017
Figure Advaxis Benign Prostatic Hyperplasia (BPH) Drugs Revenue Global Market Share (2012-2017)
Table Agennix Basic Information List
Table Agennix Benign Prostatic Hyperplasia (BPH) Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Agennix Benign Prostatic Hyperplasia (BPH) Drugs Sales Growth Rate (2012-2017)
Figure Agennix Benign Prostatic Hyperplasia (BPH) Drugs Sales Global Market Share (2012-2017
Figure Agennix Benign Prostatic Hyperplasia (BPH) Drugs Revenue Global Market Share (2012-2017)
Table ANI Pharmaceuticals Basic Information List
Table ANI Pharmaceuticals Benign Prostatic Hyperplasia (BPH) Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure ANI Pharmaceuticals Benign Prostatic Hyperplasia (BPH) Drugs Sales Growth Rate (2012-2017)
Figure ANI Pharmaceuticals Benign Prostatic Hyperplasia (BPH) Drugs Sales Global Market Share (2012-2017
Figure ANI Pharmaceuticals Benign Prostatic Hyperplasia (BPH) Drugs Revenue Global Market Share (2012-2017)
Table BHR Pharma Basic Information List
Table BHR Pharma Benign Prostatic Hyperplasia (BPH) Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure BHR Pharma Benign Prostatic Hyperplasia (BPH) Drugs Sales Growth Rate (2012-2017)
Figure BHR Pharma Benign Prostatic Hyperplasia (BPH) Drugs Sales Global Market Share (2012-2017
Figure BHR Pharma Benign Prostatic Hyperplasia (BPH) Drugs Revenue Global Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Benign Prostatic Hyperplasia (BPH) Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Benign Prostatic Hyperplasia (BPH) Drugs Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Benign Prostatic Hyperplasia (BPH) Drugs Sales Global Market Share (2012-2017
Figure Bristol-Myers Squibb Benign Prostatic Hyperplasia (BPH) Drugs Revenue Global Market Share (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Dendreo Basic Information List
Table Endo Pharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Benign Prostatic Hyperplasia (BPH) Drugs
Figure Manufacturing Process Analysis of Benign Prostatic Hyperplasia (BPH) Drugs
Figure Benign Prostatic Hyperplasia (BPH) Drugs Industrial Chain Analysis
Table Raw Materials Sources of Benign Prostatic Hyperplasia (BPH) Drugs Major Players in 2016
Table Major Buyers of Benign Prostatic Hyperplasia (BPH) Drugs
Table Distributors/Traders List
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Price (USD/Kg) and Trend Forecast (2017-2022)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (MT) Forecast by Regions (2017-2022)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share Forecast by Regions in 2022
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share Forecast by Regions in 2022
Figure United States Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure United States Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure China Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure Japan Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure India Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales (MT) Forecast by Type (2017-2022)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Price (USD/Kg) Forecast by Type (2017-2022)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales (MT) Forecast by Application (2017-2022)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Report 2017

More Publications

Need Help?

Ask a Question

Market Reports